dye Antibody

Shipped with Ice Packs
In Stock

Description

Chemical Conjugation Methods

Antibody-dye conjugation employs two primary chemical strategies:

Amine-reactive chemistry

  • Uses NHS ester dyes (e.g., Alexa Fluor 532-SE) targeting lysine residues

  • Typical protocol:

    • Dissolve dye in DMSO (10 mg/ml)

    • Add 2.5 µl dye per 100 µg antibody (5-20 molar excess)

    • Incubate 60 min at room temperature

Thiol-reactive chemistry

  • Utilizes maleimide dyes targeting cysteine sulfhydryl groups

  • Requires antibody reduction with 2.5 mM DTT before conjugation

  • Produces lower dye-to-antibody ratios (DAR) compared to amine targeting

Key comparison:

ParameterAmine ConjugationThiol Conjugation
Target residueLysineCysteine
Typical DAR4-81-3
Steric effectsHigher riskLower risk
Common dyesFITC, Alexa FluorFluorescein-5-maleimide

Dye-to-Antibody Ratio (DAR)

Critical formula for calculation:

DAR=(Amax×150,000)Antibody Concentration (mg/ml)×εdye\text{DAR} = \frac{(A_{\text{max}} \times 150,000)}{\text{Antibody Concentration (mg/ml)} \times \varepsilon_{\text{dye}}}

Where εdye\varepsilon_{\text{dye}} = extinction coefficient of dye .

Empirical findings:

  • Alexa Fluor 488: Optimal DAR = 4-8 for IgG

  • Higher DAR (>5) causes fluorescence quenching (20-50% intensity loss)

  • Plasma clearance accelerates at DAR >1.2 for near-infrared dyes

Fluorescence Intensity Benchmarks

DyeExcitation/Emission (nm)Relative Intensity vs Cy3/Cy5
Atto 550544/5852× (Cy3)
Atto 647N633/6656.5× (Cy5)
Alexa 555555/56550% (Atto 550)

Diagnostic Techniques

ApplicationKey Use CasePreferred Dye
Flow cytometryImmune cell profilingBrilliant Violet 785
Live-cell imagingReceptor traffickingiFluor 647
ImmunohistochemistryTumor marker detectionDAB Chromogen

Therapeutic Monitoring

  • Antibody-drug conjugates (ADCs) with pHrodo dyes enable real-time tracking of drug delivery

  • Trastuzumab-800CW conjugates show altered hepatic uptake at DAR >1.2

Technical Challenges and Solutions

Steric hindrance

  • Conjugation near paratope reduces antigen affinity by 30-70%

  • Site-specific labeling (e.g., Fc region) preserves binding capacity

Batch consistency

  • SiteClick technology achieves DAR variability <0.39 across 28 antibody lots

Multiplex limitations

  • Spectral overlap restricts simultaneous use to 4-6 dyes in standard flow cytometry

  • Spectral cytometry expands capacity to 40+ parameters using advanced unmixing algorithms

Emerging Innovations

  • DNA origami-dye complexes improve autoimmune antibody detection sensitivity by 3.4×

  • Qdot nanocrystals enable multiplexed tracking of 8+ targets with single-laser excitation

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Orders are typically dispatched within 1-3 business days of receipt. Delivery times may vary depending on the shipping method and destination. Please contact your local distributor for precise delivery estimates.
Synonyms
dye antibody; Nuclear pore complex protein Nup93 antibody; 93 kDa nucleoporin antibody; Dead eye protein antibody; Nucleoporin Nup93 antibody
Target Names
dye
Uniprot No.

Target Background

Function

This antibody targets a protein that plays a role in nuclear pore complex (NPC) assembly and/or maintenance.

Database Links

KEGG: dre:30172

STRING: 7955.ENSDARP00000013627

UniGene: Dr.653

Protein Families
Nucleoporin interacting component (NIC) family
Subcellular Location
Nucleus membrane; Peripheral membrane protein. Nucleus, nuclear pore complex.

Q&A

What is antibody dyeing and why is it essential for research applications?

Antibody dyeing (or labeling) involves conjugating fluorescent molecules to antibodies to enable visualization in various applications including flow cytometry, immunofluorescence microscopy, and fluorescent Western blotting. This technique is foundational to modern biological research as it allows scientists to detect specific proteins with high sensitivity and specificity. When commercial options aren't suitable—perhaps because you're working with a newly discovered protein, post-translational modification, non-traditional research model, or a custom antibody preparation—researchers must perform their own antibody labeling .

What are the primary immunofluorescence labeling strategies available to researchers?

Two principal strategies exist for immunofluorescence labeling:

  • Direct immunofluorescence: Employs a single antibody carrying a fluorophore that binds directly to the target protein. This approach offers simplicity and reduced cross-reactivity but typically provides lower signal intensity .

  • Indirect immunofluorescence: Utilizes two sequentially applied antibodies—a primary antibody that binds the target protein, followed by a fluorophore-conjugated secondary antibody recognizing the primary antibody. This method provides signal amplification but introduces potential for higher background and cross-reactivity .

How do different fluorophores impact experimental outcomes?

Fluorophores vary significantly in their spectral characteristics and physical properties, affecting their suitability for different applications:

  • Brightness (quantum yield × extinction coefficient) determines detection sensitivity

  • Photostability influences suitability for extended imaging

  • Spectral properties must match available excitation sources and detection systems

  • Physical size may impact antibody function after conjugation

For example, phycoerythrin (PE) is an excellent choice for flow cytometry due to its brightness, but it photobleaches rapidly, making it unsuitable for extended fluorescence microscopy applications .

What are the primary chemical conjugation strategies for antibody labeling?

Two predominant chemical approaches exist for antibody-fluorophore conjugation:

  • Amine chemistry:

    • Targets primary amines (lysine residues and N-terminus)

    • Employs NHS ester or succinimidyl ester reactive groups

    • Results in random labeling throughout the antibody structure

    • Suitable for intact antibodies

  • Thiol chemistry:

    • Targets sulfhydryl groups exposed by reducing inter-chain disulfide bonds

    • Utilizes maleimide-activated fluorophores

    • Provides more site-specific labeling, typically in the hinge region

    • May require optimization of reduction conditions

How is the on-bead labeling method with Protein A/G magnetic beads performed?

The on-bead labeling method offers significant advantages, particularly for antibodies in cell media at low concentrations. The protocol involves:

For amine labeling:

  • Capture antibodies on magnetic Protein A/G beads

  • Add amine-reactive fluorescent dye (typically 5-20 molar excess)

  • Incubate for 60 minutes at room temperature with mixing

  • Wash to remove excess dye

  • Elute labeled antibody with low pH buffer and neutralize immediately

  • Quantify antibody concentration and calculate dye-to-antibody ratio (DAR)

For thiol labeling:

  • Capture antibodies on magnetic Protein A/G beads

  • Reduce inter-chain disulfide bonds with DTT (2.5 mM final concentration)

  • Wash to remove reducing agent

  • Add thiol-reactive fluorescent dye

  • Incubate for 60 minutes with mixing

  • Wash to remove excess dye

  • Elute labeled antibody and neutralize

How is the dye-to-antibody ratio calculated after labeling?

The dye-to-antibody ratio (DAR) is calculated using spectrophotometric measurements:

  • Measure absorbance at 280 nm (A280) and at the λmax for the dye (Amax)

  • Calculate antibody concentration:
    Antibody Concentration (mg/ml) = [A280 - (Amax × CF)] / 1.4
    where CF = Correction factor of the dye (provided by manufacturer)

  • Calculate DAR:
    DAR = (Amax × 150,000) / [Antibody Concentration (mg/ml) × ε dye]
    where ε dye = extinction coefficient of the dye and 150,000 Da is the approximate molecular weight of an antibody

What factors influence antibody recovery after labeling procedures?

Recovery of labeled antibodies is critical for downstream applications. Studies have shown recovery rates between 50-90% for different mouse antibody isotypes after fluorescent labeling compared to simple purification . Key factors affecting recovery include:

  • Binding efficiency to Protein A/G beads

  • Losses during washing steps

  • Elution efficiency

  • Antibody aggregation due to excessive labeling

  • Buffer conditions during the labeling process

The high capacity of magnetic beads allows efficient capture of antibodies from media using small bead volumes (as little as 10 μl settled beads for 1.0 ml samples), resulting in concentrated antibody preparations suitable for cell-based experiments .

How can researchers optimize the dye-to-antibody ratio for specific applications?

The optimal DAR depends on the specific application:

  • Flow cytometry: Higher DAR often preferred for maximum sensitivity

  • Microscopy: Moderate DAR (3-6) typically optimal to balance brightness and functionality

  • Functional assays: Lower DAR (1-3) may preserve antibody activity better

Optimization involves:

  • Adjusting the molar excess of reactive dye (typically 5-20 fold)

  • Controlling reaction time and temperature

  • Empirical testing of different DARs for the specific application

  • Balancing signal strength against potential negative effects of overlabeling

Dye ChemistryAntibody Recovery (μg)Typical Dye-to-Antibody Ratio
Amine reaction with AlexaFluor 532182.9 ± 15.35.3 ± 0.04
Thiol reaction with AlexaFluor 647192.5 ± 2.93.3 ± 0.1
Thiol reaction with Fluorescein179.5 ± 5.36.8 ± 0.1

Data represents labeling of mouse IgG2A antibody using Magnetic Protein G beads

What quality control measures should be implemented for labeled antibodies?

Essential quality control measures include:

  • Spectrophotometric analysis to determine:

    • Antibody concentration

    • DAR

    • Presence of free dye

  • SDS-PAGE analysis to:

    • Confirm labeling of both heavy and light chains

    • Assess antibody purity

    • Detect potential aggregation

  • Functional testing to verify:

    • Antigen binding capability

    • Signal-to-noise ratio in intended applications

    • Stability under storage and experimental conditions

How can researchers address poor labeling efficiency?

Poor labeling efficiency can result from several factors:

  • Inadequate dye concentration: Increase molar excess of dye

  • Improper buffer conditions: Ensure optimal pH (typically 8.3-8.5 for amine chemistry)

  • Competing reagents: Avoid buffers containing primary amines (e.g., Tris) for amine chemistry

  • Insufficient reaction time: Extend incubation period

  • Degraded reactive dyes: Prepare fresh dye solutions immediately before use

  • Low antibody purity: Improve purification before labeling

What strategies can mitigate fluorophore photobleaching in imaging applications?

Photobleaching represents a significant challenge, particularly for extended imaging experiments:

  • Select appropriate fluorophores:

    • Different fluorophores have vastly different photostability properties

    • For confocal imaging, select dyes that resist photobleaching under extended laser illumination

    • For flow cytometry, photobleaching is less critical as detection time is brief

  • Optimize imaging conditions:

    • Minimize exposure time and light intensity

    • Use anti-fade mounting media

    • Consider oxygen-scavenging systems for live-cell imaging

    • Employ computational methods to correct for photobleaching

How can inconsistent labeling results between experiments be addressed?

Variability between labeling reactions often stems from:

  • Inconsistent starting materials:

    • Antibody concentration variations in source material

    • Differences in antibody purity

    • Batch-to-batch variations in dye reactivity

  • Process variations:

    • Temperature fluctuations during labeling

    • Inconsistent mixing during reaction

    • Variations in reaction time

    • pH differences in buffers

Standardization approaches include:

  • Rigorous quality control of starting materials

  • Use of automated labeling systems where possible

  • Development of standard operating procedures

  • Implementation of positive controls across experiments

What special considerations apply to labeling antibodies for super-resolution microscopy?

Super-resolution microscopy imposes unique requirements:

  • Fluorophore selection must match the specific super-resolution technique:

    • STED: Dyes with good depletion efficiency and photostability

    • PALM/STORM: Photoswitchable fluorophores

    • SIM: Bright, photostable conventional fluorophores

  • Labeling density considerations:

    • Higher precision localization often requires sparser labeling

    • Smaller labeling tags (e.g., Fab fragments) may reduce linkage error

    • Direct labeling can eliminate localization errors from secondary antibodies

  • Sample preparation becomes even more critical:

    • Background minimization is essential

    • Antibody specificity must be rigorously validated

    • Chromatic aberration must be accounted for in multi-color applications

How do researchers optimize antibody labeling for challenging applications like receptor internalization studies?

For specialized applications such as receptor internalization:

  • Dye selection considerations:

    • pH-sensitive dyes that change properties in endosomal compartments

    • Dyes resistant to lysosomal degradation

    • Brightness sufficient for tracking through multiple cellular compartments

  • Labeling strategy optimization:

    • Site-specific labeling may preserve receptor binding and trafficking

    • Controlling DAR to avoid altering internalization kinetics

    • Validating that labeled antibodies maintain native trafficking patterns

  • Experimental design factors:

    • Appropriate controls to distinguish specific from non-specific uptake

    • Time-course measurements to capture kinetics

    • Quantification methods for internalization efficiency

What emerging technologies are advancing antibody labeling capabilities?

The field continues to evolve with several promising approaches:

  • Site-specific conjugation methods:

    • Enzymatic approaches (sortase, transglutaminase)

    • Click chemistry with unnatural amino acids

    • Glycan-specific modifications

  • Advanced fluorophores:

    • Self-healing dyes resistant to photobleaching

    • Environment-responsive smart probes

    • Near-infrared fluorophores for deep tissue imaging

  • Alternative scaffolds:

    • Nanobodies with reduced size and enhanced tissue penetration

    • DNA-barcoded antibodies for highly multiplexed imaging

    • Genetically encoded fluorescent protein fusions to antibody fragments

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.